reported that CAF-derived IL-32 interacts with integrin β3 on breast cancer cells to activate the p38 MAPK signaling pathway, thereby promoting EMT, invasion, and distant metastasis, ultimately supporting tumor progression. The gene discussed is IL32; the disease is neoplasm.